CTRI/2012/03/002528招募中2 期
Clinical Evaluation of Vyoshadi Guggulu and Haritaki Churna in the Management of Dyslipidemia. - IMCRP â?? DLD â?? 2010 - 2011
Central Council for Research in Ayurvedic Sciences CCRAS0 个研究点目标入组 150 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients having
- •LDLc 100mg/dL - 160mg/dL and / or
- •Serum cholesterol 200mg/dL - 250mg/dL and / or
- •Serum Triglycerides â??150mg/dL - 250 mg/dL
- •2. Willing and able to participate in the study for 16 weeks
排除标准
- •1. Patients who have received any cholesterol lowering medication (Modern Drug) within last 8 weeks.
- •2. Patients having Type III and Type IV hypercholesterolaemia
- •3. Patients with poorly controlled Hypertension ( > 160 / 100 mm Hg)
- •4. Patients with evidence of malignancy
- •5. Patients on prolonged ( > 6 weeks) medication with corticosteoids, antidepressants, anticholinergics, immunosuppressants, estrogen replacement therapy etc. or any other drugs that may have an influence on the outcome of the study.
- •6. Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Tuberculosis, Psycho-Neuro-Endocrinal disorders, etc.)
- •7. Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
- •8. Symptomatic patient with clinical evidence of Heart failure.
- •9. Patients having uncontrolled Diabetes Mellitus i.e.HbA1c > 10%
- •10. Patients with concurrent serious hepatic disorder (defined as aspartate aminotransferase (AST) and / or alanine aminotransferase (ALT), total bilirubin or alkaline phosphatase (ALP) > 2 times upper normal limit) or renal disorders (defined as S.creatinine >1.2mg/dL), severe pulmonary dysfunction (uncontrolled asthma and chronic obstructive pulmonary disease [COPD]), inflammatory bowel disease or any other condition that may jeopardize the study..
- •11. Pregnant/ lactating females.
- •12. Patients on oral contraceptives.
- •13. Alcoholics and/or drug abusers.
- •14. H/o hypersensitivity to any of the trial drugs or their ingredients.
- •15. Patients who have completed participation in any other clinical trial during the past six (06) months.
- •16. Any other condition which the Principal Investigator thinks may jeopardize the study.
研究者
相似试验
招募中
2 期
A clinical study to see the effect of some Ayurvedic formulations in the management of Obesity.CTRI/2012/03/002527Central Council for Research in Ayurvedic Sciences CCRAS150
招募中
2 期
A clinical study to see the effect of some Ayurvedic formulations in the management of ObesityCTRI/2012/01/002377Department of AYUSH Ministry of Health Family Welfare Government of India150
招募中
2 期
A clinical study to see the effect of some Ayurvedic formulations in the management of Lipid disorders.CTRI/2012/01/002374Department of AYUSH Ministry of Health Family Welfare Government of India150
尚未招募
1 期
A Clinical Trial to study the effect of tablet Vyoshadi guggulu along with the Vaitarana Basti protocol in Rheumatoid Arthritis.CTRI/2023/06/054110Dr Nagashree
招募中
3 期
CLINICAL EVALUATION OF VYOSHADI GUGGULU AND PANCHASAMA CHURNA IN AMAVATA (RHEUMATOID ARTHRITIS)CTRI/2014/12/005331CENTRAL COUNCIL FOR RESEARCH IN AYURVEDIC SCIENCES90